Back to search
FDAFDA · Food and drugs·Recall number D-1420-2015

Felodipine Extended-Release Tablets, 2.5 mg, 100 count bottles, Rx only, Mutual Pharmaceutical Co. Inc., Philadelphia, PA --- NDC 53489-368-01

Published September 16, 2015 · Recall initiated: July 16, 2015

Summary

FDA records drug Class III recall D-1420-2015, published September 16, 2015 and initiated July 16, 2015. Recalling firm: Mutual Pharmaceutical Company, Inc.; Status: Terminated; Reported quantity: 25,272 bottles; Lot: lot #s: 6669101 & 6669201, exp 12/15 and 6708201 & 6708301, exp 8/16. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Chemical Contamination; benzophenone leached from the product label varnish

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Mutual Pharmaceutical Company, Inc.
Distributor
Nationwide
Lot
lot #s: 6669101 & 6669201, exp 12/15 and 6708201 & 6708301, exp 8/16
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Felodipine Extended-Release Tablets, 2.5 mg, 100 count bottles, Rx only, Mutual Pharmaceutical Co. Inc., Philadelphia, PA --- NDC 53489-368-01 recalled?

Yes. FDA published recall D-1420-2015 on September 16, 2015. Reported hazard: Chemical Contamination; benzophenone leached from the product label varnish

What should I do if I have this product?

Voluntary: Firm initiated · Letter